Urinary MicroRNAs as biomarkers of urological cancers: a systematic review
A Aveta, S Cilio, R Contieri, G Spena… - International Journal of …, 2023 - mdpi.com
MicroRNAs (miRNAs) are emerging as biomarkers for the detection and prognosis of
cancers due to their inherent stability and resilience. To summarize the evidence regarding …
cancers due to their inherent stability and resilience. To summarize the evidence regarding …
The role of Exosomal miRNAs in cancer
C Li, T Zhou, J Chen, R Li, H Chen, S Luo… - Journal of translational …, 2022 - Springer
Exosomal miRNAs have attracted much attention due to their critical role in regulating genes
and the altered expression of miRNAs in virtually all cancers affecting humans (Sun et al. in …
and the altered expression of miRNAs in virtually all cancers affecting humans (Sun et al. in …
Liquid biopsy at the frontier in renal cell carcinoma: recent analysis of techniques and clinical application
M Li, L Li, J Zheng, Z Li, S Li, K Wang, X Chen - Molecular Cancer, 2023 - Springer
Renal cell carcinoma (RCC) is a major pathological type of kidney cancer and is one of the
most common malignancies worldwide. The unremarkable symptoms of early stages …
most common malignancies worldwide. The unremarkable symptoms of early stages …
Epidemiology and prevention of renal cell carcinoma
T Makino, S Kadomoto, K Izumi, A Mizokami - Cancers, 2022 - mdpi.com
Simple Summary The incidence of renal cell carcinoma (RCC) rises globally with the highest
rates in developed countries. This indicates not only the impact of advanced imaging, but …
rates in developed countries. This indicates not only the impact of advanced imaging, but …
Validation in an independent cohort of MiR-122, MiR-1271, and MiR-15b as urinary biomarkers for the potential early diagnosis of clear cell renal cell carcinoma
Simple Summary The survival of patients with the most common type of kidney cancer
(called Clear cell renal cell carcinoma—ccRCC) would dramatically improve if it was …
(called Clear cell renal cell carcinoma—ccRCC) would dramatically improve if it was …
[HTML][HTML] Canadian Urological Association guideline: Management of small renal masses–Full-text
PO Richard, PD Violette, B Bhindi… - Canadian Urological …, 2022 - ncbi.nlm.nih.gov
The incidence of small renal masses (SRM) is increasing around the world largely due to the
increasing use of abdominal imaging. 1, 2 Although 10–30% of these SRM are benign, the …
increasing use of abdominal imaging. 1, 2 Although 10–30% of these SRM are benign, the …
Detection of urinary miRNAs for diagnosis of clear cell renal cell carcinoma
The lack of symptoms at the early stages of clear cell renal cell carcinoma (ccRCC) allows
the tumour to metastasize, leading to a dramatic reduction in patient survival. Therefore, we …
the tumour to metastasize, leading to a dramatic reduction in patient survival. Therefore, we …
A review on the role of long non-coding RNA and microRNA network in clear cell renal cell carcinoma and its tumor microenvironment
Q Zhang, H Ren, L Ge, W Zhang, F Song… - Cancer Cell …, 2023 - Springer
Renal cell carcinoma (RCC) is the second lethal urogenital malignancy with the increasing
incidence and mortality in the world. Clear cell renal cell carcinoma (ccRCC) is one major …
incidence and mortality in the world. Clear cell renal cell carcinoma (ccRCC) is one major …
Epigenetic biomarkers of renal cell carcinoma for liquid biopsy tests
R Kubiliute, S Jarmalaite - International journal of molecular sciences, 2021 - mdpi.com
Renal cell carcinomas (RCC) account for 2–3% of the global cancer burden and are
characterized by the highest mortality rate among all genitourinary cancers. However …
characterized by the highest mortality rate among all genitourinary cancers. However …
Novel liquid biomarkers and innovative imaging for kidney cancer diagnosis: what can be implemented in our practice today? A systematic review of the literature
Context The epidemiological signature of renal cell carcinoma (RCC) during the past
decades is explained by overdetection and overtreatment of indolent cancers; furthermore, a …
decades is explained by overdetection and overtreatment of indolent cancers; furthermore, a …